Back to search

Article

Nanocell COVID-19 vaccine elicits iNKT-licensed dendritic cells to produce high affinity antibodies neutralizing Variants of Concern

2022-04-07

Abstract excerpt

<title>Abstract</title> <p>For COVID-19 vaccines, high-affinity antigen-specific antibody, CD8+ T cell and memory B cell responses are essential to maximize protection against Variants of Concern (VOC). We report results in vitro, in mice and human volunteers immunized with bacterially-derived, non-living nanocells (EDVTM) packaged with bacterial plasmid expressing spike protein of SARS-CoV-2 and IFNγ stimulating...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f33c07a5-b29b-58d5-9e35-b1e221de77da
DOI
10.21203/rs.3.rs-1472661/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nanocell COVID-19 vaccine elicits iNKT-licensed dendritic cells to produce high affinity antibodies neutralizing Variants of ConcernDOI 10.21203/rs.3.rs-1472661/v1
Select a neighboring publication to make it the new centre.